World Library  
Flag as Inappropriate
Email this Article

Pharmaceutical industry in Switzerland

Article Id: WHEBN0040797551
Reproduction Date:

Title: Pharmaceutical industry in Switzerland  
Author: World Heritage Encyclopedia
Language: English
Subject: Fenjal, Pharmaceutical industry in Pakistan, Pharmaceutical industry in India, Merck Serono, Actelion
Publisher: World Heritage Encyclopedia

Pharmaceutical industry in Switzerland

One of the many buildings of Novartis in Basel.
The headquarters of Roche Diagnostics in Rotkreuz, Switzerland.
The headquarters of Actelion in Allschwil.

The pharmaceutical industry in Switzerland directly and indirectly employs about 135,000 people.[1] It contributes to 5.7% of the gross domestic product of Switzerland and contributes to 30% of the country's exports.[1]

Switzerland is home to many pharmaceutical companies, including very large groups, such as Novartis and Hoffmann-La Roche. In 2013, 41 life science companies had their international headquarters (and 29 more their regional headquarters) in Switzerland.[2][3]



Basel is home to Novartis (Sandoz), Hoffmann-La Roche, Basilea Pharmaceutica, Actelion and Straumann. In 2013, Novartis and Hoffmann-La Roche were respectively the second and third world biggest pharmaceutical companies (preceded by Pfizer and followed by Merck & Co. and Sanofi).[4]

Switzerland is also home to Merck Serono (Serono), Ferring Pharmaceuticals, Debiopharm, Nycomed, Janssen-Cilag, Galderma, Mondobiotech, Naari, Weleda, Octapharma and Frewitt.

What is more, many non-domestic companies have their regional headquarters in Switzerland, for instance: Biogen Idec, Amgen, Celgene, Medtronic and Onyx Pharmaceuticals.[2]

See also: Alliance Boots, Fenjal.

Life sciences

70% of the investments in life sciences in Europe are made in the United Kingdom, Germany, Ireland, the Netherlands, France and Switzerland.[2][3]

In addition to pharmaceutical companies (65 companies), Switzerland is home to many companies in the fields of biotechnology (338 companies) or medical devices and technology (341 companies).[2][3] According to KPMG, there are 120 life science companies in Basel, 132 in Zürich and 92 in the Lemanic region.[2][3]

In 2013, 41 life science companies had their international headquarters (and 29 more their regional headquarters) in Switzerland.[2][3]

In Switzerland, there are about 51,000 workers in the field of medical technologies (1,600 companies) and 13,700 on the field of biotechnologies.[5]


Basel region

According to Le Temps, there are about 900 pharmaceutical and medtech companies (50,000 workers) in the region of Basel.[5] The region of Zurich, mainly active in medical technologies employs 21,000 workers.[5]

Lemanic region

The former headquarters of Merck Serono in Geneva, which now hosts the Campus Biotech.

According to L'Hebdo, there are 750 biotech and medtech companies (20,000 employees) in the Lemanic region.[6] Among them, 450 companies develop and/or produce drugs.[6] In addition to that, there are 500 laboratories from universities and university hospitals (in the Lemanic region).[6]



Notes and references

  1. ^ a b Stephan Vaterlaus, Stephan Suter and Barbara Fischer, "The Importance of the Pharmaceutical Industry for Switzerland", A study undertaken on behalf of Interpharma, September 2011.
  2. ^ a b c d e f Site Selection for Life Sciences Companies, European Life Sciences Cluster 2013 Report, KPMG (page visited on 4 November 2013).
  3. ^ a b c d e (French) Willy Boder, "La Suisse compétitive dans les sciences de la vie", Le Temps, Tuesday 5 November 2013, p. 15.
  4. ^ a b c d (French) Willy Boder, "Le grand chambardement de la pharma", Le Temps, Monday 7 July 2014, page 17.
  5. ^ a b c (French) Dejan Nikolic, "Les sciences de la vie recrutent à Genève grâce à des ex-employés de Merck Serono", Le Temps, Tuesday 21 April 2015, page 13.
  6. ^ a b c (French) Health Valley, L'Hebdo, 2010.


  • (French) Karl Lüönd, Principe actif: la connaissance. Passé et présent de l'industrie pharmaceutique suisse, Interpharma and éditions Neue Zürcher Zeitung, 2008.

See also

External links

  • Interpharma

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.